The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Remote Irritable Bowel Syndrome (IBS) Monitoring Market Change Between 2026 And 2030?
The remote irritable bowel syndrome (IBS) monitoring market has experienced rapid expansion in recent years. It is projected to grow from $1.4 billion in 2025 to $1.63 billion in 2026, at a compound annual growth rate (CAGR) of 16.0%. This historical growth can be attributed to the increasing prevalence of irritable bowel syndrome, the development of digital health platforms, the rising adoption of telehealth services, the broader use of smartphone-based health monitoring, and the availability of cloud-based patient data systems.
The remote irritable bowel syndrome (ibs) monitoring market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $2.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.7%. This projected growth throughout the forecast period stems from factors such as heightened demand for individualized gastrointestinal care, the expanding integration of remote diagnostic solutions, the proliferation of value-based healthcare frameworks, the increasing application of predictive analytics in disease management, and boosted investments in digital therapeutics. Key trends anticipated during this period encompass the escalating utilization of AI-powered symptom analytics, the growing embrace of mobile health monitoring platforms, the wider incorporation of wearable ibs tracking devices, the development of more personalized treatment management instruments, and a stronger emphasis on solutions designed to improve patient engagement.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29175&type=smp
What Are The Main Drivers Accelerating The Growth Of The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?
The expansion of the remote irritable bowel syndrome (IBS) monitoring market is anticipated to be fueled by the rising occurrence of gastrointestinal disorders. These disorders are conditions that hinder the digestive system’s regular operation, disrupting digestion and bowel control. The surge in gastrointestinal issues primarily stems from unhealthy eating patterns, which negatively impact gut health and digestion, leading to inflammation and digestive complaints like bloating and general discomfort. By enabling early detection of triggers and continuous management, remote irritable bowel syndrome (IBS) monitoring assists in reducing the intensity of symptoms and delaying the advancement of the disease, thereby enhancing patient results and overall quality of life. For example, in February 2025, Crohn’s & Colitis Australia, an Australia-based national organization, reported that the anticipated prevalence of inflammatory bowel disease (IBD) in Australia is projected to climb from 20,511,881 cases in 2023 to 23,067,771 cases by 2030. Consequently, the increasing incidence of gastrointestinal disorders is indeed fostering the expansion of the remote irritable bowel syndrome (IBS) market.
How Are Different Segment Groups Identified Within The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?
The remote irritable bowel syndrome (ibs) monitoring market covered in this report is segmented –
1) By Component: Devices, Software, Services
2) By Application: Diagnosis, Symptom Tracking, Treatment Management, Patient Education, Other Applications
3) By End-User: Hospitals And Clinics, Homecare Settings, Research Institutes, Other End-Users
Subsegments:
1) By Devices: Wearable Monitoring Devices, Non-Wearable Monitoring Devices, Portable Monitoring Devices, Implantable Monitoring Devices
2) By Software: Data Analytics Software, Mobile Health Applications, Remote Monitoring Platforms, Cloud-Based Software Solutions
3) By Services: Teleconsultation Services, Data Management Services, Technical Support Services, Training And Education Services
Which Trends Are Shaping The Remote Irritable Bowel Syndrome (IBS) Monitoring Market Landscape?
Leading companies operating in the remote healthcare market are concentrating on creating cutting-edge technological solutions, including generative AI-driven remote patient monitoring assistants and real-time diagnostic tools, to enhance patient involvement and facilitate individualized care. A generative AI-powered remote patient monitoring assistant is an intelligent system that uses AI to analyze live health data, generate tailored insights, and automate patient communication for improved remote care delivery. For instance, in February 2025, Validic Inc., a US-based digital health firm, introduced a generative AI-powered assistant within its Validic Impact platform to bolster remote patient monitoring. This assistant automatically interprets and summarizes intricate health data, identifies health trends, produces concise data summaries, enables time-based comparisons, streamlines clinical processes, and reduces providers’ administrative load. Operating on a secure, HITRUST-certified, HIPAA-compliant infrastructure, it supports numerous health conditions and is compatible with hundreds of devices, empowering clinicians to deliver more personalized, proactive, and efficient care.
Which Industry Players Are Present In The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?
Major companies operating in the remote irritable bowel syndrome (ibs) monitoring market are Indegene, Vivante Health, Thryve Health, Heali AI Corp., Mahana Therapeutics Inc., metaMe Health Inc., Seed Health, Ayble Health, Oshi health, Salvo Health Inc., modifyhealth Inc., Food marble, nerva health, MyGiHealth, Sun Genomics, Dietahealth, Dige Health, Nori health, Sequenex, Bowelle.
Access The Complete Remote Irritable Bowel Syndrome (IBS) Monitoring Market Report:
Which Regional Market Leads The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?
North America was the largest region in the remote irritable bowel syndrome (IBS) monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote irritable bowel syndrome (ibs) monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Remote Irritable Bowel Syndrome (IBS) Monitoring Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=29175&type=smp
Browse Through More Reports Similar to the Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market 2026, By The Business Research Company
Remote Health Monitoring Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/remote-health-monitoring-global-market-report
Remote Surgery Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/remote-surgery-global-market-report
Artificial Intelligence Ai In Remote Patient Monitoring Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model